Research Topic · Peer-Reviewed

Covid and Treatment

COVID-19 treatment encompasses the pharmacological and supportive interventions used to manage infection with SARS-CoV-2, the betacoronavirus that emerged in late 2019 and joined SARS-CoV and MERS-CoV as agents capable of causing severe respiratory disease. Management is stratified by disease severity and phase: sup…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 42× across the literature 🔖 ISSN 2692-1537 🗓 Reviewed July 2026

Overview

COVID-19 treatment encompasses the pharmacological and supportive interventions used to manage infection with SARS-CoV-2, the betacoronavirus that emerged in late 2019 and joined SARS-CoV and MERS-CoV as agents capable of causing severe respiratory disease. Management is stratified by disease severity and phase: supportive and symptomatic care for mild illness, and for moderate-to-severe disease the addition of oxygen therapy, antiviral and immunomodulatory agents, anticoagulation, and organ support. Because severe disease reflects both viral replication and a dysregulated host inflammatory response, treatment strategy depends on timing, with antiviral approaches most relevant early and anti-inflammatory measures during the later hyperinflammatory phase. During the pandemic, repurposed drugs including hydroxychloroquine and chloroquine regimens were evaluated for clinical improvement, mortality, and viral kinetics, alongside interferon-based immunomodulation and cell therapy for the consequences of infection; laboratory markers such as white-cell and lymphocyte dynamics were studied to monitor response. Complications including secondary infections and vaccine-associated reactions also inform clinical decisions. Research published in this area examines therapeutic candidates, their mechanisms and measured outcomes, and the clinical course of infection, reflecting the journal's focus on the treatment of coronavirus disease.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

The Novel Coronavirus 2019 (COVID-19): A Narrative Review

Rezapour BarataliCorresponding author
Department of Public Health, Faculty of Health, Assistant Professor, PhD in Health education and promotion, Urmia University of Medical Sciences, Urmia, Iran
International Journal of Coronaviruses Cited by 2 doi:10.14302/issn.2692-1537.ijcv-20-3373

How this research is being cited

The 12 articles above have been cited 42 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Covid and Treatment, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Coronaviruses (ISSN 2692-1537).

Journal editorial board
Dr. Omeed Memar · USA Dr. SUDIPTI GUPTA · United States Dr. Jose Luis Turabian · Spain

This page summarises published research for orientation; it is not medical or professional advice.